- 专利标题： E. COLI BACTERIOPHAGE ESC-COP-14 AND USE THEREOF IN INHIBITING GROWTH OF PATHOGENIC E. COLI
-
申请号： US17258722申请日： 2019-06-07
-
公开(公告)号： US20210283202A1公开(公告)日： 2021-09-16
- 发明人: Seong Jun Yoon , Soo Youn Jun , Jee Soo Son , Hyoung Rok Paik , Hyun Joo Lee , Sang Hyeon Kang
- 申请人： Intron Biotechnology, Inc.
- 申请人地址： KR Gyeonggi-do
- 专利权人： Intron Biotechnology, Inc.
- 当前专利权人： Intron Biotechnology, Inc.
- 当前专利权人地址： KR Gyeonggi-do
- 优先权： KR10-2018-0080284 20180711
- 国际申请： PCT/KR2019/006903 WO 20190607
- 主分类号： A61K35/76
- IPC分类号： A61K35/76 ; A23L3/3571 ; A23K10/16 ; C12N7/00
摘要：
The present invention relates to a Myoviridae bacteriophage Esc-COP-14 (Accession number: KCTC 13528BP) isolated from nature, and characterized by having the ability to specifically kill Escherichia coli and having the genome represented by SEQ. ID. NO: 1, and to a method for preventing and treating the infection of pathogenic Escherichia coli using the composition comprising Myoviridae bacteriophage Esc-COP-14 as an active ingredient.
信息查询
